YANKCOM Partnership
Source: SEC Form 13F · as of Mar 2026YANKCOM Partnership holds 27 biotech & pharma companies tracked by BioSniper, totaling $12.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
27
Total value held
$12.9M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 9,861 | $2.1M |
| MRKMerck & Co., Inc. | 16,469 | $2.0M |
| JNJJOHNSON & JOHNSON | 6,211 | $1.5M |
| NVSNovartis AG | 8,313 | $1.3M |
| LLYELI LILLY & Co | 1,338 | $1.2M |
| DGXQuest Diagnostics Incorporated | 6,199 | $1.2M |
| PMPhilip Morris International Inc | 7,223 | $1.2M |
| ABTABBOTT LABORATORIES | 11,313 | $1.2M |
| AMGNAMGEN INC | 1,376 | $484K |
| ZTSZoetis Inc. | 2,806 | $332K |
| IDXXIDEXX LABORATORIES INC /DE | 330 | $185K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 274 | $74K |
| GILDGILEAD SCIENCES, INC. | 270 | $38K |
| PFEPFIZER INC | 717 | $20K |
| BMYBRISTOL MYERS SQUIBB CO | 322 | $20K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 324 | $18K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 86 | $15K |
| MCKMcKesson Corporation | 12 | $10K |
| NVONovo Nordisk A/S | 190 | $7K |
| GMOptec International, Inc. | 80 | $6K |
| TVTXTravere Therapeutics, Inc. | 100 | $3K |
| GMABGenmab A/S | 100 | $3K |
| AQSTAquestive Therapeutics, Inc. | 600 | $2K |
| DMACDiaMedica Therapeutics Inc. | 200 | $1K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 300 | $921 |
| PGNYProgyny Inc. | 35 | $594 |
| OGIORGANIGRAM GLOBAL INC. | 41 | $55 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.